Prof. Angus Dalgleish, M.D., F.R.C.P., F.R.A.C.P., F.R.C.Path, F.Med.Sci
Professor Angus Dalgleish, M.D., F.R.C.P., F.R.A.C.P., F.R.C.Path, F.Med.Sci is a renowned oncologist practicing in the United Kingdom, who splits his time between clinical patient care and research. Prof. Dalgleish serves as an advisor to a number of biopharmaceutical companies and is a principal investigator in several clinical trials. Prof. Dalgleish has been a Professor of Medical Oncology at St George's University of London and Consultant Physician at St George's Hospital since 1991. He has served as the President of the Clinical Immunology and Allergy Section of the Royal Society of Medicine. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists.
Prof. Dalgleish studied Medicine at University College London, where he obtained an MBBS and a BSc in Anatomy. Among his main interests are: immunology and melanoma, use of anti-angiogenic agents & low dose chemotherapy in resistant solid tumor disease of the prostate, colon & breast. A clinical researcher of international repute, he has made significant contributions to the study of the immunological basis of AIDS and to the field of cancer vaccines. He is the current Principal of the Cancer Vaccine Institute.
To view his bio, click on Prof. Angus Dalgleish's profile
To view his published articles, click on Prof. Angus Dalgleish's Work
MedInsight® Research Institute.
All rights reserved.
About LDNscience®
LDNscience® is a public information project of the MedInsight® Research Institute.
MedInsight® Research Institute is a U.S./U.K. based non-profit organization which serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.
MedInsight's Projects:
Dipyridamole Eye Drops
Cureiosity®
